228 related articles for article (PubMed ID: 391453)
1. Comparison of efficacy and safety of pindolol and alpha-methyldopa in treatment of mild to moderate hypertension: results of a double-blind evaluative study.
Beanlands DS; Allard PP; Wilson M; Orbeck KW; Helman AB; Lefebvre R
Clin Invest Med; 1978; 1(3-4):139-45. PubMed ID: 391453
[No Abstract] [Full Text] [Related]
2. Double-blind studies of the clinical effectiveness of prazosin.
Schnaper HW; Oberman A
Postgrad Med; 1975 Nov; Spec No():81-7. PubMed ID: 1105489
[TBL] [Abstract][Full Text] [Related]
3. Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial.
Waal-Manning HJ; Simpson FO
N Z Med J; 1974 Aug; 80(522):151-7. PubMed ID: 4608769
[No Abstract] [Full Text] [Related]
4. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
Malini PL; Strocchi E; Ambrosioni E; Magnani B
Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
[TBL] [Abstract][Full Text] [Related]
5. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
[TBL] [Abstract][Full Text] [Related]
6. Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo.
Mroczek WJ; Fotiu S; Davidov ME; Finnerty FA
Curr Ther Res Clin Exp; 1974 Aug; 16(8):769-77. PubMed ID: 4217243
[No Abstract] [Full Text] [Related]
7. Prazosin in the treatment of hypertension.
Adriaensen H; Vryens R
Practitioner; 1975 Feb; 214(1280):268-73. PubMed ID: 1096120
[TBL] [Abstract][Full Text] [Related]
8. Pindolol in hypertension: a double-blind trial.
Feltham PM; Watson OF; Peel JS; Dunlop DJ; Turner AS
N Z Med J; 1972 Sep; 76(484):167-71. PubMed ID: 4564997
[No Abstract] [Full Text] [Related]
9. Methyldopa combined with prindolol in the treatment of severe hypertension.
Seedat YK
S Afr Med J; 1974 Aug; 48(38):1608-10. PubMed ID: 4615382
[No Abstract] [Full Text] [Related]
10. The clinical evaluation of prazosin, a new antihypertensive agent.
Pitts NE
Postgrad Med; 1975 Nov; Spec No():117-27. PubMed ID: 1105484
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of prazosin as the sole agent for the treatment of hypertension: a double-blind cross-over study with methyldopa.
Bloom DS; Rosendorff C; Kramer R
Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):144-50. PubMed ID: 809230
[No Abstract] [Full Text] [Related]
12. The Australian National Blood Pressure Study.
Abernethy JD
Med J Aust; 1974 May; 1(21):821-4. PubMed ID: 4605365
[No Abstract] [Full Text] [Related]
13. [Comparison between propranolol and methyldopa in the treatment of hypertension (a double-blind trial)].
Brahm M
Ugeskr Laeger; 1973 May; 135(20):974-6. PubMed ID: 4585571
[No Abstract] [Full Text] [Related]
14. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.
Cattin L; Da Col PG
Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164
[TBL] [Abstract][Full Text] [Related]
15. [The combination of methyldopa with pindolol in the treatment of hypertension (author's transl)].
Szám I; Pálossy B
MMW Munch Med Wochenschr; 1978 Dec; 120(51-52):1719-22. PubMed ID: 105251
[TBL] [Abstract][Full Text] [Related]
16. [Guanfacine versus alpha-methyldopa in benign essential hypertension. An ambulatory group study].
Rhomberg F; Widler J
Schweiz Med Wochenschr; 1981 Dec; 111(50):1967-8. PubMed ID: 7036334
[TBL] [Abstract][Full Text] [Related]
17. Labetalol and pindolol in the treatment of hypertension: a comparative study.
Romo M; Halttunen P; Saarinen P; Sarna S
Ann Clin Res; 1979 Dec; 11(6):249-52. PubMed ID: 398184
[TBL] [Abstract][Full Text] [Related]
18. The combined use of L-alpha-methyldopa hydrazine and methyldopa in the treatment of hypertension.
Louis WJ; Vajda FJ; McNeil JJ; Doyle AE; Jarrott B
Clin Exp Pharmacol Physiol Suppl; 1978; 4():17-22. PubMed ID: 354826
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
Avigdor L; Waeber B; Brunner HR
Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
[TBL] [Abstract][Full Text] [Related]
20. Adverse reactions to pindolol administration.
Gonasun LM; Langrall H
Am Heart J; 1982 Aug; 104(2 Pt 2):482-6. PubMed ID: 7048882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
